Moscow previously announced that the total volume of produced doses of the V vaccine will reach 2 million in the near future, which will allow the authorities to start mass vaccinations in Russia.

Axar.az reports the press service of Kazakh President Kassym-Jomart Tokayev has made a statement about the planned production of the V vaccine.

"The prime minister told the president that the first and the second phase of the clinical trials were completed on 29 November. According to [Prime Minister] Askar Mamin, no side effects were registered, and the vaccine is confirming high efficacy. Starting 25 December, 3,000 volunteers will be vaccinated in phase three of the clinical trials. The trials will finish at the end of March 2021 ... In December of this year, production of the first batch of the domestic vaccine in the amount of 2 million doses will be launched", the presidential press service said.